EA
LUNG icon

Emerald Advisers’s Pulmonx LUNG Stock Holding History

Emerald Advisers’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,000
Closed -$50K – 260
2022
Q1 		$50K Buy
+2,000
New +$51.7K ﹤0.01% 235

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Emerald Advisers's LUNG Position: Q2 2022 in Review

Emerald Advisers sold out of Pulmonx (LUNG) in Q2 2022, closing a stake of 2,000 shares — an estimated $50K sold.

Emerald Advisers first reported a position in LUNG in Q1 2022 and held it in 1 quarter. The position peaked at $50K in Q1 2022. 107 funds tracked by Wall St. Rank hold LUNG as of Q2 2022.

  • Emerald Advisers reported no remaining Pulmonx position as of Q2 2022 after selling out during the quarter.
  • Emerald Advisers sold 2,000 Pulmonx shares in Q2 2022, an estimated $50K.
  • Emerald Advisers first reported a position in Pulmonx in Q1 2022 and held it in 1 quarter.
  • Emerald Advisers's Pulmonx position peaked at $50K in Q1 2022.
  • 107 funds tracked by Wall St. Rank held Pulmonx as of Q2 2022.

Based on Emerald Advisers's 13F filing for Q2 2022, filed 29 Jul 2022.